Conference Program Home
  My Program

All Times EDT

Legend:
* = applied session       ! = JSM meeting theme

Activity Details

278 Tue, 8/9/2022, 10:30 AM - 12:20 PM CC-140A
Multi-Stage and Seamless Clinical Trials — Contributed Papers
Biopharmaceutical Section
Chair(s): Inna Perevozskaya, GSK
10:35 AM A 2-In-1 Seamless Phase II/III Design with Graphical Approach in Oncology Drug Development
Linda Sun, Merck & Co, Inc.; Heng Zhou, Merck & Co., Inc.; Wen Li, Pfizer, Inc.; Calvin Jia, Merck & Co., Inc.
10:50 AM A Bayesian Adaptive Two-Stage Design for Rare Disease Clinical Trials
Xiaoqiang Xue, Syneos Health
11:05 AM Two-Stage Design for Selecting Among Treatments with Two-Dependent Binary Endpoints
Chishu Yin, Syracuse University; Pinyuen Chen, Syracuse University
11:20 AM Two-Stage Designs with Dual Endpoints
George Zhang, Bristol Myers Squibb; Olivia Tian, Bristol Myers Squibb
11:35 AM Multi-Stage Transitional Seamless Trial Designs with Different Objectives and Endpoints
Robert Anthony Tumasian III, Columbia University; Bin Cheng, Columbia University; Shein-Chung Chow, Duke University
11:50 AM Dose Selection Based on Benefit-Risk Score in Seamless Phase 2/3 Adaptive Design
Min Chen, BMS; Ivan Chan, BMS; Shuyu Chu, BMS
12:05 PM Two-Stage in Restricted Mean Survival Time with Conditional Power in Clinical Studies
Jingyu Huang, Rutgers University ; Yong Lin, Rutgers University; Weichung Joe Shih, Rutgers University; Shou-en Lu, Rutgers University; Kaifeng Lu, Allergan